Literature DB >> 16032705

Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers.

Paul K S Chan1, Tak-Hong Cheung, Ann O Y Tam, Keith W K Lo, So-Fan Yim, May M Y Yu, Ka-Fai To, Yick-Fu Wong, Jo L K Cheung, Denise P C Chan, Mamie Hui, Margaret Ip.   

Abstract

Consensus primers targeting human papillomaviruses (HPVs) have biases in sensitivity toward certain HPV types. We applied 3 primer sets (GP5+/6+, MY09/11, PGMY09/11) in parallel on 120 Chinese cervical cancer specimens. GP5+/6+ exhibited a poor sensitivity for HPV52, for which the prevalence among squamous cell cervical cancer was underestimated from 14.6% to 0%. The fact that HPV52 should rank second in prevalence among squamous cell cervical carcinoma in Hong Kong could be missed if GP5+/6+, a worldwide commonly used primer set, was selected for HPV detection. Biases in HPV type-specific sensitivity may result in misprioritization of vaccine candidates. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16032705     DOI: 10.1002/ijc.21299

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  33 in total

1.  Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens.

Authors:  Véronique Fontaine; Corinne Mascaux; Christine Weyn; Aurore Bernis; Nathalie Celio; Philippe Lefèvre; Leonard Kaufman; Christian Garbar
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

2.  Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens.

Authors:  Joseph E Tota; Agnihotram V Ramanakumar; Luisa L Villa; Harriet Richardson; Ann N Burchell; Anita Koushik; Marie-Hélène Mayrand; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

3.  Evidence that alpha-9 human papillomavirus infections are a major etiologic factor for oropharyngeal carcinoma in black South Africans.

Authors:  Cherie Paquette; Mark F Evans; Shabnum S Meer; Vanitha Rajendran; Christine S-C Adamson; Kumarasen Cooper
Journal:  Head Neck Pathol       Date:  2013-12

4.  Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk.

Authors:  M Ortiz; M Torres; L Muñoz; E Fernández-García; J Canals; A I Cabornero; E Aguilar; J Ballesteros; J Del Amo; A García-Sáiz
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.

Authors:  Jo L K Cheung; T H Cheung; Julian W T Tang; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

Review 6.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

7.  Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.

Authors:  A T Hesselink; M A P C van Ham; D A M Heideman; Z M A Groothuismink; L Rozendaal; J Berkhof; F J van Kemenade; L A F G Massuger; W J G Melchers; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

8.  Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples.

Authors:  Barbara Dal Bello; Arsenio Spinillo; Paola Alberizzi; Stefania Cesari; Barbara Gardella; Enrico Maria Silini
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948

9.  Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.

Authors:  Ming Guo; Yun Gong; Michael Deavers; Elvio G Silva; Yee Jee Jan; David E Cogdell; Rajyalashmi Luthra; E Lin; Hung Cheng Lai; Wei Zhang; Nour Sneige
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

10.  Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.

Authors:  Richard A Moore; Gina Ogilvie; Daniel Fornika; Veronika Moravan; Marc Brisson; Mahsa Amirabbasi-Beik; Anita Kollar; Thomas Burgess; Ray Hsu; Laura Towers; Jane Lo; Jasenka Matisic; Angela Brooks-Wilson
Journal:  Cancer Causes Control       Date:  2009-05-29       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.